CJC-1295 (No-DAC) + Ipamorelin
$89.99 – $116.99Price range: $89.99 through $116.99
This material is supplied solely as a laboratory research article. Buyer is responsible for ensuring lawful purchase, handling, storage, and use. We do not provide administration or therapeutic guidance.
Quality Certificates
Independent third-party lab analysis (CoA) - from our own in-house brand.
📦Also available in a stack · save up to $194.95
Glow - Advancedsave $194.95View the stack →CJC-1295 (No-DAC) + Ipamorelin - Two-Peptide GHRH/GHRP Combination, Research Reference Material
FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.

Analytical Identity
| Common name | CJC-1295 (No-DAC) + Ipamorelin |
|---|---|
| Amino-acid sequence | CJC-1295 (No-DAC) - Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Gln-Ala-His-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Gln-Ala-His-Asn-Ser-Tyr-Arg-Lys-Leu-Leu; Ipamorelin - Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| CAS Number | CJC-1295 (No-DAC) - 863288-34-0; Ipamorelin - 170851-70-4 |
| Molecular formula | CJC-1295 (No-DAC) - C152H252N44O42; Ipamorelin - C38H49N9O5 |
|---|---|
| Molecular weight | ~3367.9 g/mol (CJC-1295 No-DAC), 711.9 g/mol (Ipamorelin) |
| Appearance | White to off-white lyophilized powder |
| Physical form | Lyophilized powder |
| Purity | Not less than 98% by HPLC (see lot-specific Certificate of Analysis) |
|---|---|
| Source | Synthetic |
| Catalog / SKU | CJC-1295-Ipamorelin |
CJC-1295 (No-DAC) + Ipamorelin is supplied as a two-peptide laboratory research reference material intended strictly for in-vitro and laboratory investigation. The kit pairs a 30-mer tetrasubstituted growth-hormone-releasing hormone (GHRH) analog, CJC-1295 without the drug affinity complex (No-DAC), with a pentapeptide growth-hormone secretagogue, ipamorelin. The two components are provided as discrete lyophilized solids so that investigators can independently reconstitute, weigh, and combine them at ratios appropriate to their assay design.
The CJC-1295 (No-DAC) component (CAS 863288-34-0) is a synthetic analog of the N-terminal 1-29 fragment of human GHRH bearing four stabilizing substitutions (D-Ala at position 2, Gln at 8, Ala at 15, and Leu at 27) that reduce enzymatic cleavage by dipeptidyl peptidase-IV and endopeptidases relative to the native sequence. Its molecular formula is C152H252N44O42 with an average molecular weight of approximately 3367.9 g/mol, and its full sequence is Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Gln-Ala-His-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Gln-Ala-His-Asn-Ser-Tyr-Arg-Lys-Leu-Leu. Because this variant lacks the maleimidopropionyl "DAC" linker used to conjugate serum albumin, it presents a shorter analytical half-life profile than DAC-modified analogs, a distinction relevant to pharmacokinetic modeling and reference-standard selection.
The ipamorelin component (CAS 170851-70-4) is a C-terminally amidated pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, molecular formula C38H49N9O5, and molecular weight 711.9 g/mol. It incorporates two non-proteinogenic residues, alpha-aminoisobutyric acid (Aib) and D-2-naphthylalanine (D-2-Nal), together with a D-Phe residue, features that support conformational rigidity and chromatographic identity confirmation. This structural class is commonly cited as a ghrelin/GHS-R1a receptor ligand in the published peptide chemistry literature, distinct in scaffold from GHRH analogs such as CJC-1295 (No-DAC).
Both peptides are synthetic in origin, produced by solid-phase peptide synthesis and purified to not less than 98% by reversed-phase HPLC, with identity confirmed by mass spectrometry. Each lot is accompanied by a Certificate of Analysis reporting HPLC purity, mass-spec identity, appearance, and net peptide content; the CoA is the definitive document for lot-specific characterization and is available on request. The physical form is a white to off-white lyophilized powder for each component, suitable for gravimetric handling and reconstitution in laboratory solvents compatible with downstream analytical workflows such as LC-MS, ELISA cross-reactivity panels, receptor-binding characterization, and stability studies.
Published scientific literature has examined CJC-1295 (No-DAC) and ipamorelin, individually and as a paired GHRH/GHRP research combination, in preclinical and in-vitro contexts. PEPTIDE.Power makes no therapeutic, diagnostic, or efficacy claims regarding CJC-1295 (No-DAC) + Ipamorelin and provides no administration or dosing guidance. This material is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. It is offered exclusively to qualified researchers and institutions for laboratory reference and characterization purposes.
Physical format
Supplied as a lyophilized (freeze-dried) powder in a sealed vial. A research reference material - not a finished product and not a delivery device. Net contents per unit are shown in the product options.
Certificate of Analysis
| Issuing laboratory | Analiza Białek |
|---|---|
| Analyte | CJC-1295 (No-DAC) + Ipamorelin |
| CAS Number | CJC-1295 (No-DAC) - 863288-34-0; Ipamorelin - 170851-70-4 |
| Lot / Batch | K12PP |
| Appearance | White to off-white lyophilized powder |
| Purity (HPLC) | 99% |
| Identity | Confirmed by HPLC and mass spectrometry |
Lot-specific COA available — contact [email protected] with your lot number.
Storage & handling
Store the sealed lyophilized powder at -20 C, protected from light and moisture. After reconstitution for laboratory use, keep cold and use promptly. Handle per standard laboratory practice; a Safety Data Sheet (SDS) is available on request.
Scientific references
The following are independent, peer-reviewed publications provided for reference. They describe third-party research and are not representations by POWER BIOTECH LLC regarding this product.
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GHRH analog — https://pubmed.ncbi.nlm.nih.gov/17018654/
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects — https://pmc.ncbi.nlm.nih.gov/articles/PMC2787983/
- Beyond the androgen receptor: the role of growth hormone secretagogues including ipamorelin — https://pmc.ncbi.nlm.nih.gov/articles/PMC7108996/
Eligibility & terms of sale
This material is sold to qualified laboratory and research buyers for lawful research use only. It is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use this material only for lawful laboratory research.
FAQ
What is the purity and how is it verified?
Not less than 98% by HPLC; see the Certificate of Analysis for the lot-specific result.
What form does it ship in?
A lyophilized powder in a sealed vial.
Can you advise on dosing, reconstitution, or administration?
No. We provide batch documentation, storage, and handling information only; we do not provide dosing, reconstitution, administration, or therapeutic guidance.
Is lot-specific documentation available?
Yes - contact [email protected] with your lot number for the Certificate of Analysis.
Related reference materials
Sold by POWER BIOTECH LLC, Casper, WY 82609, United States · [email protected]. FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.
